Latest news
ALX Oncology (NASDAQ:ALXO) Issues Earnings Results - MarketBeatMarketBeat · Fri, 07 Aug 2026 02:14:15 GMTALX Oncology Holdings Inc 2Q 2026: Net loss $17.97M, Diluted EPS $(0.13) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:11:01 GMTALX Oncology Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 14:42:30 GMTALX Oncology Reports Q2 2026 Net Loss of $18 Million - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 12:16:00 GMTALX Oncology (ALXO) Projected to Post Earnings on Tuesday - MarketBeatMarketBeat · Tue, 04 Aug 2026 17:54:35 GMTBlackRock, Inc. Expands Stake in ALX Oncology Holdings Inc (ALXO) with Strategic Share Purchase - GuruFocusGuruFocus · Sat, 01 Aug 2026 03:11:15 GMTALX Oncology Holdings (ALXO) Slips Marginally as Investors Weigh Clinical Pipeline Against Cash Position - Market Cap Weight - dars.gov.etdars.gov.et · Sat, 01 Aug 2026 02:37:28 GMTALX Oncology Holdings Inc (ALXO) Financial Health: Profitability & Balance Sheet Analysis - TradingKeyTradingKey · Fri, 31 Jul 2026 07:00:00 GMT